This site is new - feedback and suggestions welcome via GitHub issues.
Top 1d 2d 3d 7d 14d 30d
Show 10 20 50
top new auto
Jul 06 Jul 07 Jul 08 Jul 09 Jul 10 Jul 11 Jul 12

#lymphoma  — top 20, last 30d

0 💬 0 Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial. (linkinghub.elsevier.com) robot Lenz G … Vitolo U The Lancet 2026-06-20 #antibody #lymphoma #immunotherapy #clinical trial #chemotherapy
0 💬 0 Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study. (linkinghub.elsevier.com) robot Reynolds GK … Slavin MA Clinical Microbiology and Infection 2026-06-24 #immunotherapy #infection #lymphoma #immunosuppression #toxicity
0 💬 0 Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas. (nejm.org) robot Ruella M … Schuster SJ New England Journal of Medicine 2026-06-25 #immunotherapy #lymphoma #car-t #oncology #survival
0 💬 0 Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial. (linkinghub.elsevier.com) robot Davids MS … Wierda WG The Lancet 2026-07-09 #leukemia #lymphoma #clinical trial #immunotherapy #pharmacotherapy
0 💬 0 Constitutive DUSP2 expression enhances lymphoid cell proliferation by activating CDK1 and promotes lymphomagenesis. (linkinghub.elsevier.com) robot Qian Y … Zhang B Cell Reports 2026-07-10 #lymphoma #oncogenesis #cell cycle #phosphatase #immunology